Literature DB >> 29804149

Advances in the diagnosis and treatment of Sjogren's syndrome.

Xiaoyun Chen1,2,3, Huaxun Wu4,5,6, Wei Wei7,8,9.   

Abstract

Sjogren's syndrome (SS) is a systemic autoimmune disease that primarily affects the exocrine glands, resulting in dryness of the eyes and mouth due to lymphocytic infiltration of the salivary and lacrimal glands along with arthritis, kidney, liver, and lung involvement, chronic fatigue, musculoskeletal pain, vasculitis, and so on. Considerable advance has been made for the classification and treatment of primary SS in the past few years. This article reviews the recent classification criteria for primary SS and briefly discusses the conventional and novel therapies of the disease.

Entities:  

Keywords:  Autoimmunity; Biological therapies; Classification criteria; Sjogren’s syndrome; Treatment

Mesh:

Year:  2018        PMID: 29804149     DOI: 10.1007/s10067-018-4153-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  40 in total

Review 1.  Diagnosis of Sjögren's syndrome: American-European and the American College of Rheumatology classification criteria.

Authors:  Vidya Sankar; Jenene L Noll; Michael T Brennan
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2014-02       Impact factor: 2.802

Review 2.  One year in review 2017: primary Sjögren's syndrome.

Authors:  Francesco Ferro; Elisa Marcucci; Martina Orlandi; Chiara Baldini; Elena Bartoloni-Bocci
Journal:  Clin Exp Rheumatol       Date:  2017-03-15       Impact factor: 4.473

3.  Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sjögren Syndrome.

Authors:  Tetsuya Kawakita; Shigeto Shimmura; Kazuo Tsubota
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2015 Mar-Apr

Review 4.  Treatment of primary Sjögren syndrome.

Authors:  Alain Saraux; Jacques-Olivier Pers; Valérie Devauchelle-Pensec
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

5.  CD22 ligation inhibits downstream B cell receptor signaling and Ca(2+) flux upon activation.

Authors:  N Sieger; S J Fleischer; H E Mei; K Reiter; A Shock; G R Burmester; C Daridon; T Dörner
Journal:  Arthritis Rheum       Date:  2013-03

6.  Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome.

Authors:  Gwenny M Verstappen; Petra M Meiners; Odilia B J Corneth; Annie Visser; Suzanne Arends; Wayel H Abdulahad; Rudi W Hendriks; Arjan Vissink; Frans G M Kroese; Hendrika Bootsma
Journal:  Arthritis Rheumatol       Date:  2017-08-13       Impact factor: 10.995

7.  Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

Authors:  Xavier Mariette; Philippe Ravaud; Serge Steinfeld; Gabriel Baron; Joelle Goetz; Eric Hachulla; Bernard Combe; Xavier Puéchal; Yvon Pennec; Bernard Sauvezie; Aleth Perdriger; Gilles Hayem; Anne Janin; Jean Sibilia
Journal:  Arthritis Rheum       Date:  2004-04

8.  Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort.

Authors:  Astrid Rasmussen; John A Ice; He Li; Kiely Grundahl; Jennifer A Kelly; Lida Radfar; Donald U Stone; Kimberly S Hefner; Juan-Manuel Anaya; Michael Rohrer; Rajaram Gopalakrishnan; Glen D Houston; David M Lewis; James Chodosh; John B Harley; Pamela Hughes; Jacen S Maier-Moore; Courtney G Montgomery; Nelson L Rhodus; A Darise Farris; Barbara M Segal; Roland Jonsson; Christopher J Lessard; R Hal Scofield; Kathy L Moser Sivils
Journal:  Ann Rheum Dis       Date:  2013-08-22       Impact factor: 19.103

Review 9.  The epidemiology of Sjögren's syndrome.

Authors:  Ruchika Patel; Anupama Shahane
Journal:  Clin Epidemiol       Date:  2014-07-30       Impact factor: 4.790

10.  The 2016 classification criteria for primary Sjogren's syndrome: what's new?

Authors:  Franco Franceschini; Ilaria Cavazzana; Laura Andreoli; Angela Tincani
Journal:  BMC Med       Date:  2017-03-31       Impact factor: 8.775

View more
  14 in total

1.  Publication activity in the field of Sjögren's syndrome: a ten-year Web of Science based analysis.

Authors:  Ahmet Akyol; Burhan Fatih Kocyigit
Journal:  Rheumatol Int       Date:  2020-10-08       Impact factor: 2.631

Review 2.  Diagnostic performance of serology against histologic assessment to diagnose Sjogren's syndrome: a systematic review.

Authors:  Luiz Claudio Viegas-Costa; Reid Friesen; Carlos Flores-Mir; Timothy McGaw
Journal:  Clin Rheumatol       Date:  2021-06-17       Impact factor: 2.980

3.  CP-25 alleviates antigen-induced experimental Sjögren's syndrome in mice by inhibiting JAK1-STAT1/2-CXCL13 signaling and interfering with B-cell migration.

Authors:  Huaxun Wu; Xiaoyun Chen; Fang Gu; Pengying Zhang; Shixia Xu; Qi Liu; Qiaolin Zhang; Xinming Wang; Chun Wang; Heinrich Körner; Wei Wei
Journal:  Lab Invest       Date:  2020-07-03       Impact factor: 5.502

4.  Sweet's Syndrome Following Therapy with Hydroxychloroquine in a Patient Affected with Elderly-Onset Primary Sjogren's Syndrome.

Authors:  Ciro Manzo; Nazareno Pollio; Maria Natale
Journal:  Medicines (Basel)       Date:  2019-11-15

5.  Deciphering potential pharmacological mechanism of Sha-Shen-Mai-Dong decoction on primary Sjogren's syndrome.

Authors:  Yuepeng Jiang; Xiaoxuan Zhao; Jie Yu; Qiao Wang; Chengping Wen; Lin Huang
Journal:  BMC Complement Med Ther       Date:  2021-03-01

Review 6.  Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.

Authors:  Amrita Srivastava; Helen P Makarenkova
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

7.  Increased Risk of Sjögren's Syndrome in Patients with Obsessive-Compulsive Disorder: A Nationwide Population-Based Cohort Study.

Authors:  Yi-Jung Chang; Jui-Cheng Tseng; Pui-Ying Leong; Yu-Hsun Wang; James Cheng-Chung Wei
Journal:  Int J Environ Res Public Health       Date:  2021-06-01       Impact factor: 3.390

Review 8.  Emerging role of exosomes in craniofacial and dental applications.

Authors:  Xin Xing; Shuang Han; Zhi Li; Zubing Li
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

Review 9.  Sjögren's Syndrome and Viral Infections.

Authors:  Zhiyong Liu; Aichun Chu
Journal:  Rheumatol Ther       Date:  2021-07-05

10.  Corneal Epithelial Stem Cell Supernatant in the Treatment of Severe Dry Eye Disease: A Pilot Study.

Authors:  Sloan W Rush; Jennifer Chain; Hiranmoy Das
Journal:  Clin Ophthalmol       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.